Novartis opens new radioligand therapy manufacturing facility in California as part of $23 billion US expansion plan: Basel Wednesday, November 12, 2025, 10:00 Hrs [IST] Novartis, ...

Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to ...

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women ...

Novartis, a global innovative medicines company, has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, CA.

The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

Swiss pharma giant Novartis announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing ...

Novartis has opened a 10,000ft² radioligand therapy (RLT) manufacturing facility in Carlsbad in the US state of California, ...

Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated ...

Interstitial lung diseases (ILD) are a heterogeneous group of chronic disorders leading to progressive lung damage and ...

Basel: Novartis, a global medicines company, has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) ...

Novartis Opens Production Site In The US. Basel-based giant Novartis is opening a new radioligand therapy production site in California. This is part of the $23 billion (CHF18.5 billion) investment pa ...

Pangaea Data’s AI platform adopted by University of Illinois Cancer Center to help clinicians uncover social drivers of ...